Videos
Watch our experts break down complex topics and suggest ways to adjust your business. Gain clarity, step-by-step.
Compliance on Alert: The New Era of Program Integrity
This episode spotlights the rising compliance pressures facing health plans, from tougher Fraud, Waste, and Abuse oversight to expanding Program Integrity requirements and new federal scrutiny across operations. In five minutes, Avalere Health experts break down the policies driving these shifts and what plans must watch now to stay compliant.
Healthcare System Readiness in Brain Health
In the final installment of our Brain Health month series, Avalere Health experts examine what it takes to close the gaps between innovation and patient access.
Aduhelm Launch: Lessons for Alzheimer’s Therapies
In this Brain Health Month installment, Avalere Health experts draw lessons from a landmark Alzheimer's launch for manufacturers navigating approval and access.
Clover Health Wins MA Stars Lawsuit: What’s Next?
Avalere Health experts discuss the recent court decision on Clover Health's Medicare Advantage Stars results lawsuit, and what health plans should be assessing for future potential impacts while appeals and next decisions play out.
Spotlight on Women’s Brain Health
In the second installment of our Brain Health Month series, Avalere Health experts discuss key insights from Dr. Roberta Diaz Brinton on menopause, brain health, and emerging opportunities to improve Alzheimer's disease outcomes in women.
Predictably Unpredictable: Medicare Risk Adjustment
Medicare risk adjustment is shifting. In five minutes, Avalere explains policy changes, RADV expansion, and how evolving models may affect payments and market strategy.
Understanding Delphi Panels: Building Expert Consensus
Avalere Health experts break down what a Delphi panel is, how it works, and why its structured methodology sets it apart from a traditional advisory board.
Brain Health Month: Precision Medicine in Alzheimer’s
In the first installment of our Brain Health Month series, Avalere Health experts discuss precision medicine, diagnostics, and patient access in Alzheimer's disease.
The Impact of CMS and HHS Rules on Responsible AI Use
CMS and HHS regulations are shaping AI use in health plans, driving transparency and accountability, and speeding responsible adoption across an increasingly automated system.
What’s Shaping Healthcare Right Now?
Introducing On the Record: Health Plan Perspectives—A rapid-fire series delivering expert clarity on major CMS and HHS rules. In five minutes, get the insights, implications, and decisive perspective leaders need now.
Federal and State Dynamics in AI Regulation
Avalere Health Advisory experts unpack the recent state legislative activity around AI in healthcare, exploring recent trends, the impact of federal executive orders, and key considerations for industry stakeholders as they navigate these shifts.
Impacts to Insurance Markets, 2026 and Beyond
Avalere Health experts discuss how they developed and deployed an analytic model to predict likely enrollment changes to assist clients in understanding the impacts on all lines of business as a result of upcoming federal policy changes.
Inside Compendia: Off-Label Applications
Avalere Health Advisory experts discuss how compendium shape off-label drug use, underscoring both benefits and risks in clinical decision-making.
Inside Compendia: Expanding Intended Use Populations
In the second installment of our Inside Compendia series, Avalere Health Advisory experts discuss how compendia can support clinical decision-making and medication access, highlighting a case study on GLP-1s.
Inside Compendia: Introduction to Clinical Drug Compendia
In the first installment of our Inside Compendia series, Avalere Health Advisory experts discuss how to engage and support life sciences companies in ways of incorporating their products into clinical compendia and guidelines.
Inside the Latest RADV Regulatory Developments
Avalere Health Advisory experts break down major updates to the CMS Medicare Advantage (MA) Risk Adjustment Data Validation (RADV) audit process, including enhanced technology, workforce expansion, and increased audit volume, and how health plans can prepare.
Unpacking the Final CY2026 CMS Part C and D Rule and Rate Announcement
Avalere Health Advisory experts explore how the Trump Administration approached Medicare Advantage and Medicare Part D policies proposed by the Biden Administration, ranging from anti-obesity medication coverage to plan payment increases
Unpacking CMS RADV: The Selection Process and Planning for the Future
Avalere experts discuss the CMS Medicare Advantage (MA) Risk Adjustment Data Validation (RADV) audit process and provide insight on how health plans can proactively plan and prepare for these audits.
AI for Health Plans: AI and Clinical Data in Action
In the third and final installment of our AI for health plans video series, Avalere is joined by experts Mia Bolton and Teddy Gedamu from Tenasol to share real-world examples of how artificial intelligence (AI) can streamline data management and improve decision-making in health plans.
AI for Health Plans: Harnessing AI to Optimize Clinical Data
In the second installment of our AI for health plans video series, Avalere is joined by experts Mia Bolton and Teddy Gedamu from Tenasol to discuss how plans are operationalizing enterprise clinical data.